Table 1.
Depside | Botanical Origin | Type of Study | Experimental Model | Activities | Results | References |
---|---|---|---|---|---|---|
Atranorin | Parmotrema saccatilobum (Taylor) Hale | In vitro | Cyclooxygenase inhibition assay | Analgesic | Inhibition of COX-1 (IC50 45 μM). Inhibition (40%) of COX-2 ranging between 17 μg/mL and 0.17 μg/mL. |
[40] |
Cladina kalbi. (Ahti) | In vivo | Male Swiss mice | Analgesic | Acetic acid-induced writhing test—200 and 400 mg/kg (p.o.)—reduction (p < 0.05) abdominal writhing by 52.6 and 61.3%, compared to control. Formalin test—200 and 400 mg/kg (p.o.) inhibition inflammatory processes (second phase) dose dependently. |
[42] | |
Cladina kalbi. (Ahti) | In vivo | Male Swiss mice | Analgesic Anti-inflammatory |
Inhibitory effect in formalin- and capsaicin-induced orofacial pain tests. Anti-inflammatory effects in the acute model of inflammation (leukocyte migration to the peritoneal cavity), carrageenan- and arachidonic acid-induced paw edema in rats. |
[43] | |
- | In vitro In silico |
α-Glucosidase assay HEK293 (Human embryonic kidney cell line) Docking studies |
Antidiabetic | N-substituted hydrazide derivatives of atranorin, more potent inhibition than the original. Weak or no cytotoxicity toward HEK293 cell line. |
[44] | |
Parmelia nepalensis (Taylor) |
In vitro | Polymorphonuclear leukocytes | Anti-inflammatory | Inhibition of LTB4 biosynthesis via non-redox mechanism. | [41] | |
Atranorin | Kigelia africana (Lam.) Benth | In vitro | Chloroquine-resistant W-2 and two field isolates (CAM10 and SHF4) of Plasmodium falciparum
LLC/MK2 monkey kidney cells |
Antimalarial | Good activity against all parasite strains (IC50 < 5 μM). Cytotoxicity at high concentrations. |
[36] |
Kigelia africana (Lam.) Benth | In vitro | Multidrug-resistant W2mef strain of Plasmodium falciparum | Antimalarial | Parasite lactate dehydrogenase assay (IC50 1.78 μM). Synergistic effects with artemether. |
[37] | |
Homalia trichomanoides (Hedw.) B. S. G. | In vitro | Candida albicans | Antimicrobial | Minimum inhibitory doses of 2.0 µg. | [29] | |
Parmelia reticulata (Taylor) |
In vitro | Sclerotium rolfsii, Rhizoctonia solani, R. bataticola, Fusarium udum, Pythium aphanidermatum and Pythium debaryanum | Antimicrobial | Maximum antifungal activity against Sclerotium rolfsii (ED50: 39.70 µg/mL). | [30] | |
Cladonia foliacea (Huds.) Willd |
In vitro | Gram-positive bacteria: Bacillus cereus, Bacillus subtilis, Staphylococcus aureus, Streptococcus faecalis, Listeria monocytogenes
Gram-negative bacteria: Proteus vulgaris, Aeromonas hydrophila. Fungi: Candida albicans, Candida glabrata |
Antimicrobial | Low activity with high MIC values (15.6 µg to 500 µg per disk against 107 cells). | [27] | |
Parmotrema dilatatum (Vain.) Hale, Parmotrema tinctorum (Nyl.) Hale |
In vitro | Mycobacterium tuberculosis | Antimicrobial | Low-activity compound (MIC value 250 μg/mL). | [31] | |
Atranorin | - | In vitro | Methicillin-resistant Staphylococcus aureus strains | Antimicrobial | Effective in counteracting adhesion to polystyrene, against biofilm formation and against MRSA. | [28] |
Stereocaulon alpinum Laurer. | In vitro | Mycobacterium aurum strains | Antimicrobial | Low-activity MIC values >/= 125 µg/mL. | [32] | |
Usnea laevis Nyl. | In vitro |
Mycobacterium tuberculosis Mycobacterial multidrug-resistant (MDR) strains (MDR-A8, MDR-V791, MDR-R, MDR-40) |
Antimicrobial | Inactive against mycobacterial strains MIC values ≥ 200 µg/mL. | [33] | |
Cladina kalbii Ahti | In vitro | TRAP, TAR, TBARS, hydroxyl radical scavenging activity, nitric oxide scavenging activity, CAT- SOD-like activity. SH-SY5Y neuroblastoma cell line |
Antioxidant | TRAP assay: 1–100 μg/mL significant antioxidant effects (dose-dependent). TAR assay: 100 μg/mL significant antioxidant capacity. TBARS: 0.1 to 100 μg/mL AAPH-induced lipoperoxidation. No hydroxyl radical/nitric oxide scavenging activity. Increase (↑) H2O2 formation in vitro ↑ superoxide degradation. |
[47] | |
Parmotrema austrosinense (Zahlbr.) Hale | In vitro | DPPH assay Anti-linoleic acid peroxidation activity |
Antioxidant | IC50: 100 µg/mL. IC50: 116 µg/mL. |
[34] | |
Hypotrachyna revoluta (Flörke) Hale | In vitro | Hydroxyl radical-scavenging activity | Antioxidant | Metabolite (11.8 mg) same activity as Trolox (1 mg). | [46] | |
Parmotrema stuppeum (Taylor) Hale | In vitro | Beta-carotene-linoleate model system | Antioxidant | 14% of antioxidant activity at 200 µg/mL. | [48] | |
Atranorin | - | In vitro | Piroplasm parasites: Babesia. bovis, Babesia bigemina, Babesia divergens, Babesia caballi, and Theileria equi
Hosts of piroplasm parasites: human foreskin fibroblasts (HFF), mouse embryonic fibroblast (NIH/3T3) Madin–Darby bovine kidney (MDBK) |
Anti-parasitic | Suppression of multiplication: IC 50
(B. bovis): 98.4 µM, IC50 (B. bigemina): 64.5 µM, IC50
(B. divergens): 45.2 µM, IC50 (B. caballi): 46.6 µM, IC50 (T. equi): 71.3 µM. Reduce (↓) Cell viability. |
[38] |
- | In vivo | BALB/c mice infected by B. microti | Anti-parasitic | ↓ B. microti multiplication in mice by 68.17%. | [38] | |
- | In vivo | Normal mammary epithelial NMuMG cells BALB/c mice with T1-induced cancer disease |
Antitumoral | ↓ Clonogenic ability of carcinoma. ↑ Apoptosis associated with the activation of caspase-3 and PARP cleavage in 4T1 cells. ↑ Depletion of Bcl-xL protein in 4T1 cells. Longer survival time, reduced tumor size, and higher numbers of apoptotic 4T1 cells. Normal NMuMG cells are less sensitive to ATR. |
[57] | |
Stereospermum acuminatissimum K. Schum. | In vitro | Urease inhibition assay Chymotrypsin inhibition assay |
Antiulcerogenic | Excellent urease inhibition IC50 (18.2 µM). No α-chymotrypsin inhibitory effect. |
[45] | |
Stereocaulon evolutum Graewe. | In vitro | HCV grown in Huh-7.5.1 human hepatic cell line | Antiviral | Interferes with the lifecycle of hepatitis C virus (HCV), inhibiting only viral entry (IC50: 22.3 µM). | [35] | |
Parmotrema rampoddense (Nyl.) Hale | In silico In vitro |
Docking studies with breast cancer oncoproteins MDA MB-231 and MCF-7 (breast cancer cell lines) |
Cytotoxic | Molecular docking studies interaction: Akt > Bax, Bcl-xL and Bcl-2 > Bcl-w proteins. IC50 (MDA MB-231) = 5.36 μM; IC50 (MCF-7) = 7.55 μM. |
[49] | |
Atranorin | Everniastrum vexans (Zahlbr. ex W.L. Culb. and C.F. Culb.) | In vitro | A549 (human lung cancer cell line) | Cytotoxic | ↓ Lung cancer cell motility and tumorigenesis by affecting AP-1, Wnt, and STAT signaling and suppressing RhoGTPase activity. | [50] |
Stereocaulon caespitosum Redinger | In vitro | SKHep1 and Huh-7 (epithelial carcinoma cell line) SNU-182 (primary cancer cell line) |
Cytotoxic | ↓ Cell growth at 80 µg/mL in all cell lines Cell cycle attenuated. ↑ Cell death through necrosis. ↓ Metastatic potential by suppression of cell migration and invasion. |
[51] | |
- | In vitro | HTB-140 (melanoma cell line) DU-145 and PC-3 (prostate cancers) normal human skin fibroblasts PNT2 (prostate epithelial cell line) |
Cytotoxic | ↓ Cancer cell proliferation, migration, and actin cytoskeleton organization. | [52] | |
Hypogymnia physodes (L.) Nyl | In vitro | Human lymphocytes- cytochalasin-B blocked micronucleus (CBMN) assay. | Cytotoxic | No significant clastogenic and antiproliferative effects on selected concentrations. | [16] | |
- | In vitro | A2780 (human ovarian cancer cell line) HT-29 (human colon cancer cell line) |
Cytotoxic | Loss in the mitochondrial membrane potential. ↑ caspase-3 activation (only in HT-29 cells) and phosphatidylserine externalization. ↑ ROS/RNS. ↑ PARP, p53, Bcl-2/Bcl-xL, Bax, p38, pp38. |
[56] | |
Atranorin | - | In vitro | A2780 (human ovarian carcinoma) HCT-116 p53+/+ and HCT-116 p53−/− (human colon carcinoma) HeLa (human cervix adenocarcinoma) SK-BR-3 (human breast adenocarcinoma) HL-60 (human promyelocytic leukemia) HT-29 (human colon adenocarcinoma) Jurkat (human T cells lymphocyte leukemia) MCF-7 (human breast adenocarcinoma) |
Cytotoxic | Cytotoxicity against all cell lines except against HeLa (especially effective against HL-60 cells (50 μM). Clonogenic inhibition ability of all tested tumor cells. Accumulation in S-phase at expense of G1/G0-phase. Lower incidence in p53-deficient cells. |
[55] |
Atranorin SPION | - | In vitro | GCSCs (gastric cancer stem cells) | Cytotoxic | Inhibition proliferation, invasion, angiogenesis, and tumorigenicity of CD44+/CD24+. ↑ Oxidative stress. ↑ Fe2+ accumulation/ferroptosis. Increase mRNA encoding apoptosis factors, COX-2 levels. Inhibition GCSC markers and GPX4, NCOA4.BRF2, CD98. Downregulation mRNA hm5C modification levels. |
[54] |
- | In vivo | NOD-scid mice | Cytotoxic Antitumor |
Smaller tumors in weight and volume. Inhibition GPX4 and SLC7A11. |
[54] | |
Atranorin | Bacidia stipata I. M. Lamb. | In vitro | A375 (melanoma cancer cell line) | Cytotoxic | Low inhibition (only high concentrations) | [55] |
Parmotrema dilatatum (Vain.) Hale |
In vitro | UACC-62 and B16-F10 (melanoma cells) 3T3 (normal cells) |
Cytotoxic | IC50: 250 µg/mL. Low cytotoxic effects on all the cell lines. |
[59] | |
Bacidia stipata I. M. Lamb. | In vitro | Androgen-sensitive (LNCaP) and androgen-insensitive (DU-145) human prostate cancer cells. | Cytotoxic | Lower activity inhibiting cancer cells only at higher concentrations (25 and 50 μM). | [60] | |
Ramalina glaucescens Kremp. | In vitro | P388 murine leukemia cell line | Cytotoxic | Moderate activity against (IC50 of >33 µM). | [53] | |
Usnea laevis Nyl. | In vitro | Human acute monocytic leukemia cell line (THP-1) | Cytotoxic | IC50: 286.13 µg/mL. Low cytotoxic effects on macrophages. |
[33] | |
- | In vitro | Calf thymus DNA | DNA-interacting agents | ATR acts as effective DNA-interacting agent. No inhibitory effect on Topo isomerase I. |
[61] | |
- | In vitro | Second and third instar larvae of the mosquito Culiseta longiareolata | Larvicidal activity | LC (50) values: 0.52 ppm. LC (90) values: 5.93 ppm. |
[39] | |
Usnea articulata (L.) Hoffm. | In vitro Ex vivo |
Neuro2A (mouse neuroblastoma) cell line Primary neural stem or progenitor cells |
Neuroprotective | Neurotrophic activity (131.73 μm at 5 μM). Gene expression of BDNF and NGF modulation. |
[62] | |
Umbilicaria antarctica Frey and I. M. Lamb. | In vitro | Red cell suspension | Photohemolytic | Significant hemolysis in a red cell suspension after irradiation of atranorin with 366 nm light. Higher in presence of nitrogen. |
[64] | |
Umbilicaria antarctica Frey and I. M. Lamb. | In vitro | Inhibition of 8-MOP-human serum albumin (HSA) photobinding. | Photoprotective | Atranorin (10 mM) and irradiation (360 nm) inhibited photobinding to HSA by 20.1%. | [63] | |
Atranorin | Parmotrema austrosinense (Zahlbr.) Hale | In vitro | Bacterial strain Lactobacillus casei | Probiotic bacteria | Moderate growth stimulating activity in terms of increased dry matter of biomass (41.1 mg) of L. casei. | [34] |
Baeomycesic acid | Thamnolia subuliformis (Ehrh.) W. Culb. | In vitro | Porcine leucocytes Sheep seminal vesicle microsomes |
Cytotoxic | Potent 5-lipoxygenase inhibitor (IC50 = 8.3 µM). Inactive against COX. |
[15] |
Thamnolia vermicularis (Sw.) Schaer. | In vitro | Human platelets | Cytotoxic | Weak 12(S)-LOX inhibitor (14.7 +/− 2.76%). | [66] | |
Thamnolia vermicularis (Sw.) Schaer. | In vitro | AGS (stomach cancer cell line) Capan-1, Capan-2 and PANC-1 (pancreas cell lines) HL-60, K-562 and JURKAT (blood cancer cell lines) NCI-H1417 (lung cancer cell line) NIH: OVCAR-3 (ovary cancer line) PC-3 (prostate cancer cell line) T47-D (breast cancer line) WiDr (colorectal cancer cell line) |
Cytotoxic | Slight anti-proliferative activity. Selective 5-LOX inhibitor. |
[65] | |
Barbatic acid | Cladonia borealis Stenroos | In vitro |
Staphylococcus. aureus NEWP0023 Enterococcus. faecalis (NEWP0012) Escherichia. coli (NEWP 0022) |
Antimicrobial | MIC values: S. aureus (NEWP0023) = 31.3 µg/mL; S. aureus (clinic) = 31.3 µg/mL; E. faecalis (NEWP0012) = 7.8 µg/mL; E. faecalis (clinic) = 31.3 µg/mL; E. coli = nt. | [68] |
Cladia longissima (Sw.) Nyl. | In vitro | Adult worms of Schistosoma mansoni | Antiparasitic | Schistosomicidal effect (death, tegumentary damages, and changes in mobility). | [18] | |
Cladia longissima (Sw.) Nyl. | In vitro | Adult mollusks of Biomphalaria glabrata
Cercariae of Schistosoma mansoni |
Antiparasitic Antimolluscal |
Molluscicidal activity against B. glabrata at 20 and 25 µg/mL. Schistosomicidal effect against the parasite S. mansoni at the second larval stage (1 µg/mL after 60 min of exposure). | [67] | |
Barbatic acid | Usnea longissima Ach. | In vitro | A549 (lung cancer cell line) | Cytotoxic | Pro-apoptotic effect (G0/G1 accumulation and poly ADP-ribose polymerase cleavage). | [69] |
Usnea longissima Ach | In vitro | Tissue culture | Cytotoxic | Slight inhibitor of tumor promoter-induced Epstein–Barr virus (EBV) activation. | [70] | |
Pyrrosia petiolosa (Christ) Ching. | In silico | With-no-lysine 1 (WNK1) kinase | Diuretic | Weak diuretic potential. | [71] | |
Diffractaic acid | Usnea diffracta Vain. | In vivo | Male ddY mice Lipopolysaccharide (LPS)-induced (hyperthermia model) Acetic acid-induced writhing and tail-pressure method (analgesic model) |
Analgesic and antipyretic | Hypothermic effect (dose of 200 mg/kg) on normal body temperature. Analgesic effect (dose of 200 mg/kg). |
[14] |
Parmelia nepalensis (Taylor) Parmelia tinctorum Despr. Ex Nyl |
In vitro | Polymorphonuclear leukocytes | Anti-inflammatory | Inhibition of LTB4 biosynthesis by specific enzyme interaction. | [41] | |
Usnea blepharea Motyka | In vitro | Gram-positive bacteria: Staphylococcus aureus, Gram-negative bacteria: Escherichia coli |
Antimicrobial | Antibacterial. Strong inhibition at 750 and 1000 ppm concentration. |
[72] | |
- | In vitro | Fusarium fujokuroi | Antimicrobial | Antifungal. MIC 16 × 10−3 mg/mL. Similar to amphotericin B, isovuconzole, terbafine, voriconazole. |
[73] | |
Usnea subcavata (Motyka) | In vitro | Mycobacterium tuberculosis | Antimicrobial | Anti-tubercular activity. High active compound (MIC value 15.6 μg/mL). |
[31] | |
Diffractaic acid | Usnea longissima Ach | In vivo | Albino Wistar rats Indomethacin-induced gastric lesions |
Antiulcerogenic | Significant gastroprotective effect. ↑ SOD and GPx activities and GSH levels ↓ lipid peroxidation ↓ myeloperoxidase and inducible NOS (iNOS) activities ↑ constitutive NOS (cNOS) activity. |
[74] |
- | In vitro | U87MG (glioblastoma multiforme cell line) PRCC cells (neurons from Sprague Dawley® rats) |
Cytotoxic | IC50 value (PRCC) = 122.26 mg/L. IC50 value (U87MG) = 35.67 mg/L. High antioxidant capacity on PRCC cells (10 mg/L). |
[75] | |
Parmelia nepalensis (Taylor) Parmelia tinctorum Despr. ex Nyl |
In vitro | HaCaT (human keratinocyte cell line) | Cytotoxic | Inhibition cell growth (IC50 values of 2.6 mM). No changes on LDH activity, cytostatic effects. |
[76] | |
Usnea aciculifera Vain. | In vitro | HeLa (human epithelial carcinoma cell line) NCI-H460 (human lung cancer cell line) MCF-7 (human breast cancer cell line) |
Cytotoxic | Strong cytotoxic activity against all cell lines (100 μg/mL). | [77] | |
Protousnea magellanica (Mont.) Krog | In vitro | MCF-7 (breast adenocarcinoma cell line) HeLa (cervix adenocarcinoma cell line) HCT-116 (colon carcinoma cell line) |
Cytotoxic | Cytotoxic effects in a concentration-dependent manner (2.5–100 μM). No increase intracellular ROS level. No prevention of oxidative injury induced by t-butylhydroperoxide in HeLa cells. |
[78] | |
Diffractaic acid | - | In vitro | Mitochondrial TrxR purified from rat lung | Cytotoxic | Moderate inhibitory effect on Thioredoxin reductase (TrxR). | [79] |
Usnea longissima Ach | In vitro | Tissue culture | Cytotoxic | Slight inhibitor of tumor promoter-induced Epstein–Barr virus (EBV) activation. | [14] | |
Usnea longissima Ach | In vivo | Titanium-implanted rabbits | Proapoptotic agent | ↑ Caspase-2, Csp-8, Csp-9, and Csp-3 activation. ↑ Strong myeloperoxidase and inducible nitric oxide synthase activities. ↓ SOD activity and total glutathione level. | [116] | |
Divaricatic acid | Evernia mesomorpha Nyl. | In vitro | Gram-positive bacteria: Staphylococcus aureus, Enterococcus faecium, Bacillus subtilis, Micrococcus luteus, Streptococcus epidermidis, Streptococcus mutans
Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella typhimurium, Vibrio vulnificus Fungi: Candida albicans |
Antimicrobial | Effective against Gram+ bacteria (MIC values ranging from 7.0 to 64.0 μg/mL) and Candida albicans. | [81] |
- | In vitro | Gram-positive bacteria: Staphylococcus aureus
Gram-negative bacteria: Escherichia coli, Mycobacteria: Mycobacterium tuberculosis Protozoan: Plasmodium berghei liver stage (LS) parasites, Plasmodium falciparum blood stage (BS) parasites |
Antimicrobial Antiplasmodial |
No antibacterial/antimycobacterial activity. Low antiplasmodial activity. Low LS activity (IC50 = 77.3 μM), high BS potential (IC50 = 142.1 μM). Plasmodial FAS-II enzyme (PfFabI and PfFabZ) inhibition. |
[86] | |
Divaricatic acid |
- | In vitro | Pseudomonas aeruginosa | Antimicrobial | ↓ Pseudomonas aeruginosa virulence factors expression by inhibiting quorum sensing. | [23] |
Ramalina aspera Räsänen | In vitro | Mollusk Biomphalaria glabrata Cercariae of the helminth Schistosoma mansoni | Molluscicidal and cercaricide | High toxicity against: adult snails (5 μg/mL) and embryos (20 μg/mL after 6 h of exposure) cercariae (10 μg/mL after 30 min of exposure). |
[82] | |
Dirinaria aspera Hasanen | In vitro | UACC-62 and B16-F10 (human and murine melanoma cells) 3T3 normal cells |
Cytotoxic | Cytotoxic against both lines (LC50 50.2 μM (UACC-62) LC50 643.7 Μm (B16-F10). More selective against melanoma cells than normal cells. |
[59] | |
Canoparmelia texana | In vitro | PBMCs (peripheral blood mononuclear cell) | Cytotoxic | No cytotoxicity (IC50 > 200 μM). | [82] | |
Cetraria ornata Müll.Arg. | In vitro | Tissue culture | Cytotoxic | Moderate inhibitor of tumor promoter-induced Epstein–Barr virus (EBV) activation. | [70] | |
Evernic acid | Evernia prunastri (L.) Ach. | In vitro | Gram-positive bacteria: Staphylococcus aureus
Gram-negative bacteria: Pseudomonas aeruginosa, Escherichia coli Fungi: Candida albicans |
Antimicrobial | Inhibition of the growth of all tested microorganisms (MIC values = from 0.98 to 125 µg/mL). | [84] |
Evernia prunastri (L.) Ach. | In silico | Prediction of toxicity risk based on fragment-based toxicity estimation | Toxicity | No mutagenic, no tumorigenic, no reproductive alterations and no irritant effects. | [84] | |
Evernia prunastri (L.) Ach. | In vitro | Candida albicans biofilms | Antimicrobial | Slow maturation and reduction in biofilms with MBIC50 ≤ 12.5 µg/mL. | [85] | |
Evernia prunastri (L.) Ach. | In vitro | HeLa (Human epithelial cervical cancer) | Cytotoxic | Strong cytotoxic and antiproliferative effects (25 and 50 µg/mL). | [91] | |
Evernic acid |
Evernia prunastri (L.) Pseudoevernia furfuraceae (L.) Zopf. |
In vitro | A549 (human lung cancer cells) HUVEC (umbilical vein endothelial cells) |
Cytotoxic | No significant effects in healthy cells. Decrease in proliferation in cancer cells (12.5–100 µg/mL). |
[90] |
Evernia prunastri (L.) Ach. | In vitro | Glioblastoma multiforme cell line: A-172 and T98G cell lines. |
Cytotoxic | Reduction A-172 cell viability at 10 µM. Mildly cytotoxic on T98G cell line. Anti-IDO1 (32.8 % inhibition). Anti-COX-2 (50.7%) inhibition. Anti-hyaluronidase activity (IC50 600 µg/mL). Weak antioxidant properties (DPPH (750 µg/mL) CUPRAC (250 µg/mL)) (21.2 % SOD and 20 % GPx inhibition). Inhibition of BChE. (85.9 %) No AchE inhibition. BBB Permeability (8.6 × 10−6 (cm/s) at 4 h. |
[92] | |
Evernia prunastri (L.) Ach. | In vitro | U373-MG (human glioblastoma astrocytoma cell line) SH-SY5Y (human neuroblastoma cell line) |
Neuroprotective | ↑ Cell viability; GSH/GSSG ratio; antioxidant enzymes expression. ↓ ROS; lipid peroxidation; protein carbonyls; Caspase-3 activity; Nrf2 pathway activation. |
[87] | |
- | In vitro | Primary neurons | Neuroprotective | Suppression/inhibition MPP+ induced: - Apoptosis (↑ Bcl-2/↓ Bax/Caspase-3) - Mitochondrial Dysfunction - Astrocyte Activation (GFAP expression) - Oxidative stress (↓ ROS production) - NF-κB Signaling Pathway. |
[88] | |
Evernic acid | - | In vivo | MPTP-induced mouse model C57BL/6 mice Rotarod | Neuroprotective | Attenuation of motor dysfunction Reduction in dopaminergic neuronal death and astroglial activation. |
[88] |
Evernia prunastri (L.) Ach. | In vitro | MM98 (malignant mesothelioma cell line) A431 (vulvar carcinoma cell line) HaCaT (human keratinocyte cell line) | Wound healing | No wound closure effects. | [89] | |
Isolecanoric acid | Glarea lozoyensis | In vitro | SH-SY5Y (human dopaminergic neuroblastoma cell line) L-BMAA for amyotrophic lateral sclerosis (ALS) model and rotenone for Parkinson’s disease (PD) model |
Neuroprotective | GSK3β and CK1 inhibition. ↓ Oxidative stress, mitochondrial damage, apoptosis, and cell death. |
[93] |
Lecanoric acid | - | In vitro | α-Glucosidase | Antidiabetic | Active against α-glucosidase (85.9% of inhibition; IC50 value of 350 µM) | [98] |
Umbilicaria ntárctica Frey and I. M. Lamb. | In vitro | PTP1B enzyme activity and kinetic analysis | Antidiabetic Antiobesity |
Moderate inhibition PTP1B activity IC50 31 μM. | [99] | |
Melanelia subaurifera (Nyl.) Melanelia fuliginosa (Fr. Ex Duby) Ess | In vitro | Gram-positive bacteria: Bacillus cereus, Bacillus subtilis, Staphylococcus aureus.
Gram-negative bacteria: Escherichia coli, Proteus mirabilis Fungi: Aspergillus flavus, Candida albicans, Mucor. mucedo, Trichoderma viride, Cladosporium cladosporioides, Fusarium oxysporum |
Antimicrobial | Antimicrobial activity against all tested bacteria and fungi with MIC values of 0.5 to 1 mg/mL. | [24] | |
Lecanoric acid | Parmelia cetrata Ach. | In vitro | Gram-negative bacteria: Aliivibrio fischeri
Nematode Caenorhabditis elegans |
Antimicrobial Antihelmintic |
Antibacterial activity (100% inhibition at 100 µM). Antihelmintic effect (80% mortality at 100 µg/mL). |
[4] |
Melanelia subaurifera (Nyl.) Melanelia fuliginosa (Fr. ex Duby) Ess | In vitro | DPPH assay | Antioxidant | Slight DPPH scavenging activity (IC50 value of 424.5 μg/mL) and reducing power (0.0165 at 125 μg/mL). | [24] | |
Parmotrema grayanum (Hue) Hale. | In vitro | Superoxide radical (SOR) Nitric oxide radical DPPH assay |
Antioxidant | Good antioxidant activity: SOR assay (IC50 value = 91.5 µmol), DPPH (IC50 value = 34 µmol), NOR assay (IC50 value = 53.5 µmol). | [94] | |
Parmotrema stuppeum (Nyl.) Hale | In vitro | Beta-carotene-linoleate model system | Antioxidant | Thirty-six percent of antioxidant activity at 500 µg/ml. | [48] | |
Hypocenomyce scalaris (Ach. ex. Lilj | In vitro | Colorectal cancer cells (HCT116 and DLD-1) Human keratinocytes HaCaT cell line |
Cytotoxic | Moderate cytotoxic effects against colon HCT116 cells. ↓ Slight Axin2 expression in HCT116 cells. |
[95] | |
Parmotrema tinctorum (Despr. ex Nyl.) Hale. | In vitro | Hep-2 (human larynx carcinoma cells) MCF7 (human breast carcinoma cells) 786-0 (human kidney carcinoma cells) B16-F10 (murine melanoma cells) |
Cytotoxic | Slight activity against all tested cancer cell lines (IC50 values > 50 µg/mL). | [97] | |
Melanelia subaurifera (Nyl.) Melanelia fuliginosa (Fr. ex Duby) Ess | In vitro | Hela (human epithelial carcinoma cells) A549 (human lung carcinoma cells) LS174 (human colon carcinoma cells) | Cytotoxic | Weak cytotoxic activity against Hela cells (IC50 value of 124 μg/mL) and against A549 and LS174 cells (IC50 value of 200 μg/mL). | [24] | |
Lecanoric acid | - | In vitro | HCT-116 (human colon cancer cell line) | Cytotoxic | Inhibition cell colony formation already at 0.03 μg/mL. Induction of a G2 cell cycle block. Arrest of cells in the M phase. Upregulated expression of cyclin B1 and pH3. Inactive CDK1. More cell death in cancer cells than in primary human immune and endothelial cells. |
[96] |
- | In vitro | Mitochondrial TrxR from rat lung | Cytotoxic | High inhibitory effect on Thioredoxin reductase (TrxR). | [79] | |
Methyl evernate | Ramalina fastigiata (Pers.) Ach. | In vitro | Gram-positive bacteria: Bacillus cereus, Staphylococcus aureus.
Gram-negative bacteria: Escherichia coli, Proteus mirabilis Fungi: Aspergillus flavus, Candida albicans, Mucor mucedo, Trichoderma viride, Cladosporium cladosporioides, Fusarium oxysporum, Alternaria alternata, Penicillium expansum |
Antimicrobial | Inhibition against all tested microorganisms. MIC values (from 0.125 to 1 mg/mL). | [24] |
Ramalina fastigiata (Pers.) Ach. | In vitro | DPPH assay Reducing power assay |
Antioxidant | Low DPPH radical scavenging activity (IC50 value of 391.57 μg/mL). Isolated components showed higher reducing power than lichen extracts. | [24] | |
Ramalina fastigiata (Pers.) Ach. | In vitro | Hela (human epithelial carcinoma cells) A549 (human lung carcinoma cell line) LS174 (human colon carcinoma cells) |
Cytotoxic | IC50 values of 46.45 μg/mL (Hela cell line), 76.84 μg/mL (A549 cell line), and 161.37 μg/mL (LS174 cell line). | [24] | |
Olivetoric acid | Pseudevernia furfuracea var. ceratea (Ach.) D. Hawksw. | In vitro | RATECs (rat adipose tissue endothelial cells) | Anti-angiogenic | ↓ Proliferation. Disruption of endothelial tube formation. Depolymerization effects on F-actin stress fibers. |
[104] |
Pseudevernia furfuracea var. ceratea (Ach.) D. Hawksw. | In vitro | Gram-positive bacteria: Staphylococcus aureus, Bacillus cereus, Bacillus subtilis, Streptococcus faecalis, Listeria monocytogenes.
Gram-negative bacteria: Escherichia coli, Pseudomonas aeruginosa, Pseudomonas vulgaris, Yersinia enterocolitica, Aeromonas hydrophila, Pseudomonas syringae, Klebsiella pneumoniae, Salmonella typhimurium. Fungi: Aspergillus niger, Penicillium notatum, Fusarium solani, Fusarium moniliforme, Fusarium oxysporum, Fusarium. culmorum, Candida albicans, C.glabrata, Alternaria. tenuissima, A. citri, A. alternata, Gaeumannomyces graminis. |
Antimicrobial | Active against all bacteria and yeast except K. pneumoniae, P. aeruginosa, and P. syringae. Active against all tested fungi except A. citri, A. tenuissima, A.niger, and G. graminis. |
[100] | |
Pseudevernia furfuracea (L.) Zopf | In vitro | Cultured human amnion fibroblasts | Antioxidant | ↓ Cell viability (IC50 values of 571.27 mg/mL) <50 mg/L no oxidative stress and genotoxicity. |
[101] | |
Pseudevernia furfuracea (L.) Zopf | In vitro | HLs (cultured human lymphocytes) | Antioxidant | ↑ Total antioxidant capacity. | [16] | |
Olivetoric acid | Pseudevernia furfuracea (L.) Zopf | In vitro | U87MG (glioblastoma multiforme cell line) PRCC cells (neurons from Sprague Dawley® rats) |
Cytotoxic | ↓ Cell viability (IC50 values of 125.71 mg/mL, for PRCC cells and 17.55 mg/L for U87MG cells). ↑ 8-OH-dG levels. LDH activity and oxidative DNA damage. |
[102] |
Pseudevernia furfuracea (L.) Zopf | In vitro | HepG2 (human hepatocellular carcinoma cells) | Cytotoxic | Cytotoxicity with 100–400 mg/L. Upregulation of pro-apoptotic genes (BAK, CASP6, CASP7, CASP8, FADD, FAS, FASLG). |
[103] | |
Perlatolic acid | - | In silico | Microsomal prostaglandin E2 synthase 1 | Anti-inflammatory | Potent inhibitor of microsomal prostaglandin E2 synthase-1 (IC50 = 0.43 µM). | [106] |
Cetrelia monachorum (Zahlbr.) W.L. Culb. and C.F. Culb. | In vitro In vivo |
Stimulated A549 lung epithelial adenocarcinoma cells Stimulated HEK-293 cells Thioglycollate-induced C57BL/6J male murine peritonitis model |
Anti-inflammatory | Microsomal prostaglandin E2 synthase-1 inhibition (IC50 = 0.4 µM), 5-Lipoxygenase inhibition (IC50 = 1.8 µM for cell-based assay and IC50 = 0.4 µM for purified enzyme). Tumor necrosis factor alpha-induced NF-kB (IC50 = 7 µM). Inhibition of leukocyte recruitment. |
[107] | |
Stereocaulon sp. | In vitro | Methicillin-resistant Staphylococcus aureus strains | Antimicrobial | MIC90 value of 32 µg/mL. Synergic action with gentamicin and antagonism action with levofloxacin. | [105] | |
Cladina confusa (Sant.). Folmm and Ahti | In vitro | Cultures of peritoneal macrophage cells from mice | Immune modulating | ↑ Hydrogen peroxide release (10.48 nmol). Slight NO release activity. |
[108] | |
Cladonia portentosa (Dufour) Coem. | In vitro Ex vivo |
Neuro2A (mouse neuroblastoma) cell line Primary neural stem or progenitor cells |
Neuroprotective | Neurotrophic activity (125.34 μm at 0.5 μM). AChE inhibition activity (IC50 = 6.8 μM). Potent proneurogenic activity. Gene expression of BDNF and NGF modulation. ↑ Acetyl H3 and H4 protein levels. |
[63] | |
Ramalic acid/Obtusatic acid |
Ramalina fraxinea (L.) Ach. Ramalina fastigiata (Pers.) Ach. |
In vitro | Gram-positive bacteria: Bacillus cereus, Bacillus subtilis, Staphylococcus aureus.
Gram-negative bacteria: Escherichia coli, Proteus mirabilis Fungi: Aspergillus flavus, Aspergillus niger, Candida albicans, Mucor mucedo, Trichoderma viride, Cladosporium cladosporioides. |
Antimicrobial | Inhibition against all tested microorganisms. MIC values (from 0.125 to 1 mg/mL). | [24] |
Ramalic acid/Obtusatic acid |
Ramalina fraxinea (L.) Ach. Ramalina fastigiata (Pers.) Ach. |
In vitro | DPPH assay Reducing power assay |
Antioxidant | Slight to moderate antioxidant activity (DPPH radical scavenging activity with IC50 value of 324.61 μg/mL and reducing power of 0.0142 at 125 µg/mL). Isolated components showed higher reducing power than lichen extracts. |
[24] |
- | In vitro | HaCaT (human keratinocyte cell line) | Cytotoxic | No significant inhibitory activity against LTB (4) production via non-mediation by redox reactions. No cytotoxic activity. |
[76] | |
Ramalina fraxinea (L.) Ach. Ramalina fastigiata (Pers.) Ach. |
In vitro | Hela (human epithelial carcinoma cell line) A549 (human lung carcinoma cell line) LS174 (human colon carcinoma cell line) |
Cytotoxic | IC50 value (Hela) 43.24 μg/mL; IC50 value (A549) 93.98 μg/mL; IC50 value (LS174) 74.28 μg/mL. | [24] | |
Sekikaic acid | Dirinaria consimilis (Stirt.) D. D. Awasthi | In vivo | STZ-induced type 2 diabetic albino rat model | Antidiabetic | ↑ α-glucosidase and α-amylase inhibition. ↓ Plasma glucose levels (44.17%), low-density. lipoprotein, total cholesterol, and total glycerides. |
[111] |
Ramalina roesleri Nyl | In vitro | Gram-positive bacteria: Bacillus subtilis, Staphylococcus aureus, Streptomyces viridochromogenes, Streptococcus mutans.
Gram-negative bacteria: Escherichia coli. |
Antimicrobial | Maximum antimicrobial activity against E. coli (78% inhibition), moderate against S. mutans, S. aureus, and S. viridochromogenes (60%, 50% and 55% inhibition, respectively), and low against B. subtilis (15% inhibition). | [109] | |
Sekikaic acid | Ramalina farinacea (L.) Ach | In vitro | Respiratory syncytial virus | Antimicrobial | Potent antiviral action against a recombinant strain rg respiratory syncytial virus (IC50 5.69 µg/mL) and respiratory syncytial virus A2 strain (IC50 7.73 µg/mL). | [110] |
Ramalina roesleri Nyl | In vitro | DPPH assay | Antioxidant | Good antioxidant activity: DPPH radical assay (IC50 value = 11.24 µg/mL). | [109] | |
Heterodermia obscurata (Nyl.) Trevisan | In vitro | Superoxide radical (SOR) Nitric oxide radical DPPH assay |
Antioxidant | Good antioxidant activity: SOR assay (IC50 value = 82.0 µmol), DPPH (IC50 value = 32.6 µmol). No nitric oxide radical activity. |
[94] | |
Dirinaria consimilis (Stirt.) D. D. Awasthi | In vitro | Ferric ion reducing power and hydroxyl radical assay. | Antioxidant | Good antioxidant activity: hydroxyl radical assay (IC50 value = 41.5 µg/mL) and ferric ion assay (IC50 value = 42.0 µg/mL). | [33] | |
Niebla homalea (Ach.) Rundel and Bowler | In vitro | MCF-7 (human hormone-dependent breast) A2780 (ovarian cancer cell) |
Cytotoxic | No antiproliferative activity. | [112] | |
Squamatic acid | Cladonia uncialis (L.) F. H. Wigg. | In vitro | Gram-positive bacteria: Staphylococcus aureus
Gram negative bacteria: Escherichia coli, Fungi: Candida albicans |
Antimicrobial | Weak antibacterial activity (MIC = 1250.0 mg/mL against S. aureus). | [113] |
Thamnolia vermicularis (Sw.) Schaer | In vitro | PC-3 (prostate cancer cells) | Cytotoxic | Weak antiproliferative effect. | [114] | |
Thamnolic acid | Usnea florida (L.) F.H. Wigg | In vitro | Gram-positive bacteria: Bacillus cereus, Bacillus subtilis, Listeria monocytogenes, Staphylococcus aureus, Enterococcus faecalis, Enterobacter aerogenes, Micrococcus luteus.
Gram-negative bacteria: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus vulgaris, Salmonella typhimurium, Yersinia enterocolitica. Mycobacteria: Mycobacterium tuberculosis. Fungi: Candida parapsilosis, Candida albicans, Candida globrata, Aspergillus niger, Aspergillus flavus, Fusarium moniliforme, Rhizopus sp., Alternaria brassicola, Sclerotium rolfsii, Fusarium solani |
Antimicrobial | Antifungal: Alternaria alternate, Aspergillus fumigatus and Sclerotium rolfsii with MIC values of 400, 400, and 200 µg/mL, respectively. Anti-yeast: Candida krusei with MIC value of 400 µg/mL. Antibacterial: Bacillus cereus, Bacillus subtilis, and Proteus vulgaris with MIC value of 400 µg/mL and Listeria monocytogenes and Micrococcus luteus with MIC value of 200 µg/mL. |
[115] |
Thamnolia vermicularis (Sw.) Schaer. | In vitro | PC-3 (prostate cancer cells) | Cytotoxic | Weak antiproliferative effect. | [114] |